Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Current Evidence and Emerging Diagnostic Technologies
British Journal of Hospital Medicine · 20.03.2026 · 87 (3)
DOI: 10.31083/bjhm52081 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Hospital Medicine, online erschienen am 20.03.2026. Verfasst von Qinmei Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis, Pancreatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tongji Hospital Scientific Research Fund Project.
Abstract (Originalsprache)
Autoimmune pancreatitis (AIP) is a relatively rare chronic fibroinflammatory disorder of the pancreas caused by autoimmune mechanisms. Patients with this condition generally show a clear response to glucocorticoid therapy. Notably, its clinical and imaging features often resemble those of pancreatic cancer (PC), particularly when AIP presents as a focal mass. In such cases, clinicians may confuse the two diseases. Given that AIP and PC differ considerably with respect to their biological behavior and treatment, diagnostic errors can lead to unnecessary surgery or delayed treatment. Consequently, it is essential to accurately distinguish between these conditions. Recent diagnostic advances, including the application of liquid biopsy and artificial intelligence, are now being evaluated as alternative approaches to conventional diagnostic methods, and may contribute to improving the distinction between AIP and PC. In this review, we summarize the current evidence, outline the clinical profile of AIP, and compare AIP with PC with respect to epidemiological, clinical, serological, imaging, and histopathological dimensions. In addition, we discuss the advantages and limitations of these new diagnostic tools. Furthermore, we propose a practical three-stage diagnostic algorithm based on the present guidelines. This stepwise approach may provide a practical method for integrating routine and emerging tests for evaluating patients with suspected AIP or PC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430030 Wuhan, Hubei, China.
Förderung
- Tongji Hospital Scientific Research Fund Project
Zitieren
APA
Wang, Q., & Wang, B. (2026). Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Current Evidence and Emerging Diagnostic Technologies. British Journal of Hospital Medicine, 87(3). https://doi.org/10.31083/bjhm52081
Vancouver
Wang Q, Wang B. Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Current Evidence and Emerging Diagnostic Technologies. British Journal of Hospital Medicine. 2026;87(3). doi:10.31083/bjhm52081
BibTeX
@article{Wang2026,
author = {Wang, Qinmei and Wang, Bo},
title = {Differentiating Autoimmune Pancreatitis From Pancreatic Cancer: Current Evidence and Emerging Diagnostic Technologies},
journal = {British Journal of Hospital Medicine},
year = {2026},
volume = {87},
number = {3},
doi = {10.31083/bjhm52081}
}
EUVIMED